These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38702528)

  • 21. Quality of Life and Burden of Moderate-to-Severe Atopic Dermatitis in Adult Patients Within the Asia-Pacific Region: A Cross-sectional Survey.
    Chu CY; Chan Y; Wananukul S; Cheng H; Chandran NS; Bhat R; Son SW; Liao HF; Gardiner S; Ng QQ; Yeo SH; Chen SB; Kataoka Y
    Dermatol Ther (Heidelb); 2024 Sep; 14(9):2479-2493. PubMed ID: 39103673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.
    Coutanceau C; Stalder JF
    Dermatology; 2014; 229(3):248-55. PubMed ID: 25196258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation.
    Chiricozzi A; Ortoncelli M; Schena D; Gori N; Ferrucci SM; Babino G; Napolitano M; Fargnoli MC; Stingeni L; Rossi M; Romanelli M; Balestri R; Pellegrino M; Parodi A; Bertoldi AM; Palazzo G; Antonelli F; Pitino A; Tripepi G; Fabbrocini G; Balato A; Marzano AV; Girolomoni G; Ribero S; Peris K
    Am J Clin Dermatol; 2023 Nov; 24(6):953-961. PubMed ID: 37322324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience.
    Londoño J; Perez L; Moreno S; Chapman E; Garcia MB; Celis AM; Muñoz MA; Castillo D; Sánchez J; Arevalo Y; Lozano A; Alvis-Zakzuk NJ; Muñoz C; Botero L; Beltran C; García E
    World Allergy Organ J; 2023 Apr; 16(4):100763. PubMed ID: 37091550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Influence of Atopic Dermatitis on Health-Related Quality of Life in Bangladesh.
    Nagata A; Kazi T; Akter Z; Nody FA; Khan MS; Shahriar ASM; Islam MS; Nakagawa T; Inui S
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.
    Chan S; Cornelius V; Cro S; Harper JI; Lack G
    JAMA Pediatr; 2020 Jan; 174(1):29-37. PubMed ID: 31764962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis.
    Paller AS; Pinter A; Wine Lee L; Aschoff R; Zdybski J; Schnopp C; Praestgaard A; Bansal A; Shumel B; Prescilla R; Bastian M
    Adv Ther; 2024 Mar; 41(3):1046-1061. PubMed ID: 38194047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of Moderate to Severe Atopic Dermatitis in Adults from France, Italy, and the UK: Patient-Reported Outcomes and Treatment Patterns.
    Kleyn CE; Barbarot S; Reed C; Losi S; von Arx LB; Robert C; Anderson P; Grond S; Costanzo A
    Dermatol Ther (Heidelb); 2022 Aug; 12(8):1947-1965. PubMed ID: 35913548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations Between Shower and Moisturizing Practices with Atopic Dermatitis Severity: A Prospective Longitudinal Cohort Study.
    Rakita U; Kaundinya T; Silverberg JI
    Dermatitis; 2023; 34(5):425-431. PubMed ID: 36917546
    [No Abstract]   [Full Text] [Related]  

  • 30. Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry.
    Larsen HH; Vittrup I; Ruge IF; Elberling J; Skov L; Ibler K; Jemec GB; Mørtz CG; Bach RO; Bindslev-Jensen C; Dalager M; Agner T; Deleuran M; Vestergaard C; Thyssen JP
    Acta Derm Venereol; 2022 Aug; 102():adv00760. PubMed ID: 35670330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physician Perception of Disease Severity and Treatment Outcomes for Children and Adolescents with Atopic Dermatitis in Emerging Economies.
    Tang MBY; Fatani M; Wiggins S; Maspero J
    Dermatol Ther (Heidelb); 2022 Apr; 12(4):999-1013. PubMed ID: 35349107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).
    Simpson EL; Prajapati VH; Leshem YA; Chovatiya R; de Bruin-Weller MS; Ständer S; Pink AE; Calimlim BM; Lee WJ; Teixeira H; Ladizinski B; Hu X; Yang Y; Liu Y; Liu M; Grada A; Platt AM; Silverberg JI
    Dermatol Ther (Heidelb); 2024 May; 14(5):1127-1144. PubMed ID: 38696027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of dermatology consultations in secondary care on treatment outcome and quality of life in new adult patients with atopic dermatitis.
    Baron SE; Morris PK; Dye L; Fielding D; Goulden V
    Br J Dermatol; 2006 May; 154(5):942-9. PubMed ID: 16634899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry.
    Silverberg JI; Gold LS; Desai S; Golant A; DiRuggiero D; Fenske DC; Li A; Dawson Z; Muñoz Maldonado Y; Ho K; Callahan K; Simpson EL
    J Dermatolog Treat; 2024 Dec; 35(1):2396382. PubMed ID: 39322226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden, Control, and Treatment of Moderate to Severe Atopic Dermatitis in 2021: A United States Patient Survey Study.
    Lio P; Mackie D; Bates D; Mulvihill E; Patel M; Kim Y; Shi V
    J Drugs Dermatol; 2023 Feb; 22(2):119-131. PubMed ID: 36745377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study.
    Calzavara-Pinton P; Čelakovská J; Lapeere H; Holzer G; Al-Ahmad M; Chu CY; Ferrucci SM; Kataoka Y; Rossi M; Fomina DS; Chung WH; Tzellos T; Fougerousse AC; Wu J; Ardeleanu M; Ozturk ZE
    Adv Ther; 2023 Dec; 40(12):5366-5382. PubMed ID: 37801232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
    Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment outcomes of patients with Atopic Dermatitis (AD) treated with dupilumab through the Early Access to Medicines Scheme (EAMS) in the UK.
    O'Kane D; Davis L; Ardern-Jones M; Laws P; Shaw L; Cork M; Velangi S; Cooper HL; Hudson R; Smith AB; Rout R
    Ulster Med J; 2021 May; 90(2):70-76. PubMed ID: 34276083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
    Silverberg JI; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Fuxench ZC; Simpson EL
    Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials.
    Penton H; Jayade S; Selveindran S; Heisen M; Piketty C; Ulianov L; Jabbar-Lopez ZK; Silverberg JI; Puelles J
    Dermatol Ther (Heidelb); 2023 Nov; 13(11):2549-2571. PubMed ID: 37747670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.